|
---|
Category:Report
MONTHYEARML24289A0932024-10-0404 October 2024 ACMUI 2024 Bylaws Subcommittee Draft Report October 4, 2024 ML24274A1922024-09-30030 September 2024 GEH Vallecitos Boiling Water Reactor License Termination Plan Environmental Assessment ML24275A0752024-09-30030 September 2024 TLR-RES/DE/REB-2024-16, Integration of Safety, Security, and Safeguards During Design and Operations - a Technical Assessment and Regulatory Considerations for Advanced Reactor and Advanced Fuel Fabrication Facilities ML24270A1282024-09-26026 September 2024 Licensing Actions Received Month of March 2024 ML24256A1702024-09-19019 September 2024 Results of the NRCs Section 610 Review of the Physical Protection of Byproduct Material ML24053A1032024-08-22022 August 2024 Final Rule ASME 2021-2022 Congressional Review Act Summary ML24221A1452024-08-0808 August 2024 ACMUI Subcommittee on Financial Assurance Draft Report, August 8 2024 ML24185A2682024-07-0303 July 2024 ACMUI Training and Experience (T&E) for All Modalities Subcommittee Final July 3, 2024 ML24214A3272024-04-30030 April 2024 Environmental Assessment and Finding of No Significant Impact for the Construction Permits for the Kairos Hermes 2 Test Reactors - Draft Report for Comment ML24120A2452024-04-24024 April 2024 ACMUI Spring 2024 Eye90 Subcommittee Final Report, Dated April 24 2024 ML24106A0982024-04-15015 April 2024 Advisory Committee on the Medical Uses of Isotopes (Acmui), Akesis Galaxy Rti Draft Licensing Guidance, Final Report, April 15, 2024 ML24116A2572024-03-16016 March 2024 Subcommittee on Yttrium-90 Microsphere Brachytherapy Eye90 Microspheres Device, Dated March 16 2024, Draft Report ML24018A1152024-01-19019 January 2024 Acu Msrr - Historic and Cultural Resources ML23338A2572023-12-14014 December 2023 Kairos Power LLC - Summary Record of Decision ML23333A0142023-11-27027 November 2023 Attachment F - Groundwater Tek Inc - Peer Review Study Final-1 ML23333A0172023-11-27027 November 2023 Attachment I - Chin - the Cooling Canal System at the FPL-Turkey-Point Power Station ML23229A2272023-11-0909 November 2023 Response to SRM-M230814 - Rulemaking - Final Rule - Comment Response Document - Emergency Preparedness for Small Modular Reactors and Other New Technologies ML23251A0462023-09-30030 September 2023 Technical Report - Review of Documents Related to Tank 12H Grout Formulations ML23194A1352023-09-0707 September 2023 OMB 3150-0007, Final Supporting Statement for 10 CFR Part 34, Licenses for Radiography and Radiation Safety Requirements for Radiographic Operations ML23192A7672023-08-21021 August 2023 Intercontinental Energy Corporation Final Completion Review Report Review and Approval ML22353A5992023-06-21021 June 2023 Enclosure - NMSS VLSSIR Wg Report and Implementation Guidance ML23097A1712023-05-0808 May 2023 Review of New and Potentially Significant Information for the Holtec Environmental Impact Statement for a Consolidated Interim Storage Facility for Spent Nuclear Fuel in Lea County, New Mexico ML22271A8622023-03-24024 March 2023 OMB-3150-0017 Final Supporting Statement for 10 CFR Part 30 Rules of General Applicability to Domestic Licensing of Byproduct Material ML22320A0752023-02-28028 February 2023 Draft Supporting Statement- Requests to Indian Tribes for Information (3150-0245) ML22318A1272023-01-0303 January 2023 Final OMB Supporting Statement: NRC Form 314 ML22133A0462022-11-10010 November 2022 Response to SRM-M220323: Final Rule-Backfitting and Issue Finality Assessment for Fitness for Duty Drug Testing Requirements ML22133A0522022-11-10010 November 2022 Response to SRM-M220323: Final Rule-Response to Public Comments for Fitness for Duty Drug Testing Requirements SECY-20-0109, Rulemaking: Regulatory Basis for Reporting Requirements for Nonemergency Events at Nuclear Power Plants Rulemaking2022-11-0404 November 2022 Rulemaking: Regulatory Basis for Reporting Requirements for Nonemergency Events at Nuclear Power Plants Rulemaking ML21267A0942022-09-30030 September 2022 Rulemaking: Final Rule: Comment Response Document: Incorporate by Reference American Society of Mechanical Engineers Boiler and Pressure Vessel Code and Operations and Maintenance Code ML21267A0982022-09-30030 September 2022 Rulemaking: Final Rule: Annotated Public Comments Document: Incorporate by Reference American Society of Mechanical Engineers Boiler and Pressure Vessel Code and Operations and Maintenance Code ML22117A2072022-08-16016 August 2022 OMB 3150-0120, Supporting Statement Draft for NRC Form 313 Application for Materials License, and NRC Forms 313A ML22165A1662022-07-20020 July 2022 OMB 3150-0055, Final Supporting Statement for Title 10 of the Code of Federal Regulations Part 75 Safeguards on Nuclear Material - Implementation ML22130A1542022-07-0707 July 2022 Final OMB Supporting Statement for 10 CFR Part 150 Exemptions and Continued Regulatory Authority in Agreement States and Offshore Waters ML22178A0662022-05-24024 May 2022 SRMC-CWDA-2022-00006, Rev. 0, Fiscal Year 2022 Savannah River Site Liquid Waste Facilities Performance Assessment Maintenance Program ML22084A6102022-04-11011 April 2022 NRC Communication with American Board of Health Physics (Abhp) in 2019 Thru 2022 ML21196A1002022-03-0202 March 2022 Rulemaking: Final Rule: Comment Response Document American Society of Mechanical Engineers Code Cases RG 1.84, Rev 39; RG 1.147, Rev 20; and RG 1.192, Rev 4 ML22032A0012022-02-28028 February 2022 Rulemaking; Proposed Rule; Unofficial Redline Rule Language for the Proposed Rule - Regulatory Improvements for Production and Utilization Facilities Transitioning to Decommissioning ML22200A2692022-02-0202 February 2022 5Q1.2-302, Rev. 31, Proceduradiation Monitoring - Water Sampling Analysis ML22021B2992022-01-21021 January 2022 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39, Release of Patients Administered Radioactive Materials, Review and Comment on the Draft Civaderm Device Licensing Guidance, Final Report, January 21, 2022 ML21350A4522021-12-15015 December 2021 Enclosure - Materials RAI Response Clarifications ML21280A1032021-12-0606 December 2021 Updated Biological Assessment of Impacts to Federally Listed Species Under NMFS Jurisdiction for SONGS Decommissioning ML21341A5642021-12-0101 December 2021 Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comment on Draft Proposed Revision 2 to Regulatory Guide 8.39, Draft Report, December 15, ML21341A5592021-12-0101 December 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on RG 8.39 Release of Patients Administered Radioactive Materials, Review and Comments on the Draft Civaderm Device Licensing Guidance, Draft Report, December 1, 2021 ML21341A5612021-11-29029 November 2021 Advisory Committee on the Medical Uses of Isotopes (Acmui), Subcommittee on Alpha Dart, Review and Comment on Draft Licensing Guidance Alpha Tau Alpha Dart Manual Brachytherapy, Draft Report, December 15, 2021 ML21294A3422021-11-24024 November 2021 COVID-19 Public Health Emergency Oversight Activities Assessment Phase B Report ML21172A2822021-10-19019 October 2021 Physical Security Requirements for Category II Fuel Cycle Facilities Information Sheet (HALEU Related) ML21286A8002021-10-15015 October 2021 Enclosure 1 - Request for Supplemental Information and Observation for the Model No. CR3MP Package ML21288A1262021-10-14014 October 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Radionuclide Generator Knowledge and Practice Requirements, Final Report, October 14, 2021 ML21287A6312021-10-14014 October 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Emerging Radiopharmaceutical Therapy Knowledge Requirements in Theranostics Subcommittee, Final Report, October 14, 2021 ML22012A0702021-10-0404 October 2021 Advisory Committee on the Medical Uses of Isotopes (ACMUI) Subcommittee on Medical Events, Draft Report, October 4, 2021 2024-09-30
[Table view]Some use of "" in your query was not closed by a matching "". Category:Miscellaneous
MONTHYEARML24289A0932024-10-0404 October 2024 ACMUI 2024 Bylaws Subcommittee Draft Report October 4, 2024 ML24270A1282024-09-26026 September 2024 Licensing Actions Received Month of March 2024 ML24053A1032024-08-22022 August 2024 Final Rule ASME 2021-2022 Congressional Review Act Summary ML24185A2682024-07-0303 July 2024 ACMUI Training and Experience (T&E) for All Modalities Subcommittee Final July 3, 2024 ML24106A0982024-04-15015 April 2024 Advisory Committee on the Medical Uses of Isotopes (Acmui), Akesis Galaxy Rti Draft Licensing Guidance, Final Report, April 15, 2024 ML24116A2572024-03-16016 March 2024 Subcommittee on Yttrium-90 Microsphere Brachytherapy Eye90 Microspheres Device, Dated March 16 2024, Draft Report ML23338A2572023-12-14014 December 2023 Kairos Power LLC - Summary Record of Decision ML23229A2272023-11-0909 November 2023 Response to SRM-M230814 - Rulemaking - Final Rule - Comment Response Document - Emergency Preparedness for Small Modular Reactors and Other New Technologies ML23194A1352023-09-0707 September 2023 OMB 3150-0007, Final Supporting Statement for 10 CFR Part 34, Licenses for Radiography and Radiation Safety Requirements for Radiographic Operations ML22271A8622023-03-24024 March 2023 OMB-3150-0017 Final Supporting Statement for 10 CFR Part 30 Rules of General Applicability to Domestic Licensing of Byproduct Material ML22320A0752023-02-28028 February 2023 Draft Supporting Statement- Requests to Indian Tribes for Information (3150-0245) ML22318A1272023-01-0303 January 2023 Final OMB Supporting Statement: NRC Form 314 ML22133A0522022-11-10010 November 2022 Response to SRM-M220323: Final Rule-Response to Public Comments for Fitness for Duty Drug Testing Requirements ML22133A0462022-11-10010 November 2022 Response to SRM-M220323: Final Rule-Backfitting and Issue Finality Assessment for Fitness for Duty Drug Testing Requirements SECY-20-0109, Rulemaking: Regulatory Basis for Reporting Requirements for Nonemergency Events at Nuclear Power Plants Rulemaking2022-11-0404 November 2022 Rulemaking: Regulatory Basis for Reporting Requirements for Nonemergency Events at Nuclear Power Plants Rulemaking ML21267A0982022-09-30030 September 2022 Rulemaking: Final Rule: Annotated Public Comments Document: Incorporate by Reference American Society of Mechanical Engineers Boiler and Pressure Vessel Code and Operations and Maintenance Code ML21267A0942022-09-30030 September 2022 Rulemaking: Final Rule: Comment Response Document: Incorporate by Reference American Society of Mechanical Engineers Boiler and Pressure Vessel Code and Operations and Maintenance Code ML22117A2072022-08-16016 August 2022 OMB 3150-0120, Supporting Statement Draft for NRC Form 313 Application for Materials License, and NRC Forms 313A ML22165A1662022-07-20020 July 2022 OMB 3150-0055, Final Supporting Statement for Title 10 of the Code of Federal Regulations Part 75 Safeguards on Nuclear Material - Implementation ML22130A1542022-07-0707 July 2022 Final OMB Supporting Statement for 10 CFR Part 150 Exemptions and Continued Regulatory Authority in Agreement States and Offshore Waters ML22084A6102022-04-11011 April 2022 NRC Communication with American Board of Health Physics (Abhp) in 2019 Thru 2022 ML21196A1002022-03-0202 March 2022 Rulemaking: Final Rule: Comment Response Document American Society of Mechanical Engineers Code Cases RG 1.84, Rev 39; RG 1.147, Rev 20; and RG 1.192, Rev 4 ML22032A0012022-02-28028 February 2022 Rulemaking; Proposed Rule; Unofficial Redline Rule Language for the Proposed Rule - Regulatory Improvements for Production and Utilization Facilities Transitioning to Decommissioning ML22200A2692022-02-0202 February 2022 5Q1.2-302, Rev. 31, Proceduradiation Monitoring - Water Sampling Analysis ML21286A8002021-10-15015 October 2021 Enclosure 1 - Request for Supplemental Information and Observation for the Model No. CR3MP Package ML21242A0592021-09-30030 September 2021 Biological Assessment of Impacts to Federally Listed Species Under NMFS Jurisdiction for SONGS Decommissioning ML22004A2362021-07-31031 July 2021 CAP88 E-Plan Evaluation Final ML22004A2312021-07-23023 July 2021 CAP88 E-Plan Eval ML21173A0712021-07-19019 July 2021 Final Supporting Statement for 10 CFR Part 31, (3150-0016), 2021 Information Collection Renewal ML21091A2502021-04-0101 April 2021 2021 Qtr 2 Active Vendors, Active Products ML21091A2492021-04-0101 April 2021 2021 Qtr 2 Active Vendors Report ML21091A2512021-04-0101 April 2021 2021 Qtr 2 Inactive Vendors Report ML21091A2542021-04-0101 April 2021 2021 Qtr 2 Inactive Vendors, Inactive Products ML21067A1552021-03-0303 March 2021 Rhode Island Quarterly Monitoring Call Summary ML21085A5762021-03-0101 March 2021 COVID-19 Public Health Emergency Oversight Activities Assessment - Phase B Working Group Charter ML20303A0042020-11-0303 November 2020 PRM-50-103 - Regulatory History for Measurement and Control of Combustible Gas Generation and Dispersal ML20252A0772020-10-20020 October 2020 ISG-029 Comment Responses ML20246G3882020-09-0101 September 2020 Response to NRC Comments ML21132A1722020-07-31031 July 2020 Cra Summary - QA Criteria and 10 CFR 50.59 for Nuclear Power Plant Components Produced Using Advanced Manufacturing Technologies ML20195B1672020-07-24024 July 2020 Final 2020 SS for 3150-0223 NRC Form 749 LVS ML20198M3892020-07-10010 July 2020 Cumulative Effects of Regulation - Updates to Integrated Schedule Supplement - July 2020 ML20192A0432020-07-0202 July 2020 Attachment 2: ASM for Access Authorization and Fingerprinting at Independent Spent Fuel Storage Installation ML20205L6162020-07-0101 July 2020 July 28, 2020, NRC Spent Fuel Storage and Transportation Issue Resolution Plan ML20181A2122020-06-30030 June 2020 Enclosure 1 - Request for Supplemental Information ML20160A3922020-06-12012 June 2020 2020 Final Supporting Statement IAEA May 2020 ML20126G2612020-05-25025 May 2020 2020 Draft OMB Collection, Supporting Statement 10 CFR Part 63 ML20100J2662020-04-29029 April 2020 Louisiana Energy Services - Amendment 84, Enclosure 2, Safety Evaluation Report ML20091H1092020-03-31031 March 2020 Pilot Project 5 Final Report ML20091H1032020-03-31031 March 2020 Pilot Project 2 Final Report ML20091H1042020-03-31031 March 2020 Pilot Project 3 Final Report 2024-09-26
[Table view]Some use of "" in your query was not closed by a matching "". |
Text
Congressional Review Act Summary AGENCY: U.S. Nuclear Regulatory Commission TITLE OF ACTION: Implementation of Quality Assurance Criteria and 10 CFR 50.59 for Components Produced Using Advanced Manufacturing Technologies TYPE OF ACTION: White Paper LEVEL OF SIGNIFICANCE: Non-Major AGENCY IDENTIFICATION: 3150 RIN AND/OR DOCKET ID: N/A DATE OF ISSUANCE: July 2020 STATUTORY OR JUDICIAL DEADLINE: N/A DESCRIPTION OF ACTION:
The U.S. Nuclear Regulatory Commission (NRC) is revising its guidance to address the use of advanced manufacturing technologies (AMTs) to develop and install components for nuclear applications. Industry has communicated plans to use AMTs and has identified the 10 CFR 50.59 process as the regulatory path for initial additive manufacturing (AM) components. The first AMT-fabricated component installed in a U.S. nuclear power plant was a thimble plugging device (TPD), which was fabricated using an AM process. The AM TPD was installed in Exelon's Byron Generating Station, Unit 1 during the plants March 2020 refueling outage.
Another licensee is planning to install four AM wing channel fasteners this year.
Regulation 10 CFR 50.59 establishes the conditions under which licensees may make changes to their facilities (e.g., repair or replacement activities using an AMT) as described in the Final Safety Analysis Report (FSAR); make changes to their procedures as described in the FSAR; and conduct tests or experiments not described in the FSAR, without obtaining a license amendment pursuant to 10 CFR 50.90. This regulation in conjunction with other regulatory requirements and processes contribute to determining the safety of a planned change, test, or experiment. These other requirements and processes include elements of procedure review, quality assurance requirements (including design control, procurement, vendor oversight, and document control), technical specifications, post-modification testing, surveillance testing, maintenance activities, in-service inspection, etc., all of which must be adhered to by licensees.
The revised guidance clarifies that the regulatory requirements and processes that apply do not differ based on the manufacturing technique used in fabricating the component.
ANALYSIS:
The NRC expects that there are no quantifiable benefits or costs to the NRC staff or industry as a result of the revision because the guidance only clarifies the applicability of existing requirements and processes to a new manufacturing technique for use in nuclear applications.
The industry benefits from the additional flexibility in choosing the manufacturing technique used
in fabricating components used for nuclear applications and from the additional clarity and regulatory certainty the revised guidance provides.
- Is there an annual effect on the economy of $100 million or more?
No, there is not an annual effect on the economy of $100 million or more.
- Is there a major increase (typically 10% - 20%) in costs for consumers, individual industries, Federal, State, or local government agencies, or to geographical regions?
No, there is not a major increase in costs for consumers, individual industries, Federal, State, or local government agencies, or geographical regions.
- Is there a significant adverse effect on competition, employment, investment, productivity, innovation, or on the ability of U.S.-based enterprises to compete with foreign-based enterprises in domestic and export markets?
No, use of the document should not affect competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete with foreign-based enterprises in domestic and export markets.
SUMMARY
The NRC believes that issuing this document is not a major action under the Congressional Review Act because the document only clarifies the applicability of existing requirements and processes for components fabricated using AMTs and developed and installed for nuclear applications. The guidance is not legally binding and would not result in a net economic impact of more than $100 million annually.
AGENCY CONTACT: Angella Love Blair Office of Nuclear Material Safety and Safeguards 301-415-3453 Angella.LoveBlair@nrc.gov